Top News

FDA pauses J&J’s Covid-19 vaccine due to rare blood clotting events in six women. FDA: "As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S."

primary article image

PermaLink

Berkeley Lovelace Jr.

CNBC

Related: @US_FDA, US FDA

Delay in Australia COVID-19 vaccination rollout after AstraZeneca shots restricted to 50 years and older (due to risk of rare cases of blood clots), while people under the age of 50 to take Pfizer’s COVID-19 vaccine

primary article image

PermaLink

Paulina Duran

Reuters


Regeneron's COVID-19 antibody cocktail shown to prevent symptomatic infections in people exposed to Covid-19 patients, with 72% protection during the first week and 93% protection after that. The Company to seek FDA approval for prevention

primary article image

PermaLink

Squawk Box

YouTube

Related: yahoo, CNBC

CNBC: Why Covid vaccinated people still need to take protective measures: takes time to reach full immunity, “breakthrough case”, vaccine less effective on Covid variants

primary article image

PermaLink

Cory Stieg

CNBC


Pfizer & BioNTech update on their Covid vaccine: 91.3% effective for 6 months in preventing symptomatic cases, 95.3% - 100% effective in preventing severe disease, 100% effective in preventing South Africa variant

primary article image

PermaLink

Reuters Staff

CNBC

Related: pfizer

Pfizer & BioNTech say their Covid-19 vaccine showed 100% efficacy and no major safety issues in youths ages 12 to 15 in a phase 3 clinical trial of 2,260 participants

primary article image

PermaLink

Lauren Mascarenhas

CNN

Related: BioNTech, POLITICO

Insider interview: BioNTech Co-founders Özlem Türeci and Ugur Sahin on developing COVID-19 vaccine, mRNA technology for cancer treatment, European vaccine rollout, life, and much more

primary article image

PermaLink

Mathias Döpfner

Business Insider


NIAID: "AstraZeneca may have included outdated information (Covid vaccine trial) ... may have provided an incomplete view of the efficacy data" AstraZeneca: "the primary analysis and the results were consistent with the interim analysis"

primary article image

PermaLink

Sam Meredith

CNBC

Related: ABC News, AstraZeneca

Oxford-AstraZeneca Covid vaccine shown 79% efficacy in its 32,000-people US study, 100% effective against severe or critical symptomatic disease, no serious safety issues observed. The Company to file for FDA approval

primary article image

PermaLink

Staff Writer

ox

Related: The Hill, STAT, New York Times

European Medicines Agency: Oxford-AstraZeneca COVID vaccine is "safe and effective". Italy and Germany to restart rolling out this vaccine

primary article image

PermaLink

Staff Writer

euronews

Related: Neue Zürcher Zeitung, zdf, Süddeutsche.de, NPR - National Public Radio

Europe divided over Oxford-AstraZeneca Covid vaccine. More countries join to suspend its use while WHO and EMA assert conviction on its safety

primary article image

PermaLink

Staff Writer

BBC

Related: Spiegel, CBS News, AP - The Associated Press, New York Times

Trump urges Americans to get COVID vaccine: "I would recommend to a lot of people who don't want to get it." "A great vaccine." "A safe vaccine"

primary article image

PermaLink

Fox News

YouTube

Related: CNN

Germany, France, & Italy joined other countries to suspend use of Oxford-AstraZeneca COVID-19 vaccine over blood clots concern. WHO & European Medicines Agency continue supporting the vaccine's safety

primary article image

PermaLink

Frank Jordans

AP - The Associated Press

Related: Spiegel, BBC, The Hill, The Washington Post

Document shows Tesla had 450 COVID-19 cases after reopening last May

primary article image

PermaLink

Michael Ruiz

Fox Business

Related: New York Times, The Verge

The 3rd wave coronavirus sweeping Europe. Italy in lockdown again, France and Germany may be next

primary article image

PermaLink

Barbie Latza Nadeau

The Daily Beast

Related: DW.COM, CNBC

Biden: U.S. will have enough Covid vaccine for every adult by end of May. This is two months ahead of the Administration's initial promise

primary article image

PermaLink

Kevin Breuninger

CNBC

Related: @POTUS

Merck to help Johnson & Johnson to manufacture its Covid vaccine

primary article image

PermaLink

Kevin Liptak

CNN

Related: @CBSNews, The Washington Post

Johnson & Johnson CEO on Covid vaccine. Observers on what the J&J vaccine means for the economy and markets

primary article image

PermaLink

Bloomberg

YouTube

Related: YouTube

Johnson & Johnson to ship 4 million doses of its one-shot Covid vaccine in U.S in 1-2 days. Both FDA and CDC have signed off this vaccine over the weekend. Officials cautioned supply shortage

primary article image

PermaLink

Sharon Lafraniere

New York Times

Related: NPR - National Public Radio

Live stream: FDA committee review of Johnson & Johnson Covid vaccine

primary article image

PermaLink

US FDA

YouTube

Latest News

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine

13 Apr 2021, 7:52 AM, Staff Writer, US FDA


FDA halts use of Johnson & Johnson vaccine due to rare blood clotting issues in six women

13 Apr 2021, Berkeley Lovelace Jr., CNBC


Regeneron CEO on FDA request for expanded EUA of Covid antibody drug

12 Apr 2021, 3:15 PM, Squawk Box, YouTube


Regeneron to seek U.S. OK for COVID-19 cocktail to be used for prevention

12 Apr 2021, 3:00 PM, Reuters Staff, yahoo


Regeneron to request FDA clearance to use Covid antibody drug as a preventative treatment

12 Apr 2021, Berkeley Lovelace Jr., CNBC


Australia abandons COVID-19 vaccination targets after new advice on AstraZeneca shots

11 Apr 2021, 11:43 PM, Paulina Duran, Reuters


So you got vaccinated: Here's why you can't let your guard down yet to stay safe

02 Apr 2021, Cory Stieg, CNBC


Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

01 Apr 2021, 11:52 AM, Staff Writer, pfizer


Pfizer Covid vaccine is 91% effective in updated data, protective against South African variant

01 Apr 2021, Reuters Staff, CNBC


Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

31 Mar 2021, 12:38 PM, Staff Writer, BioNTech


Pfizer-BioNTech vaccine 100 percent effective in teens

31 Mar 2021, Staff Writer, POLITICO


Pfizer/BioNTech says its Covid-19 vaccine is 100% effective and well tolerated in adolescents

31 Mar 2021, Lauren Mascarenhas, CNN


Fauci discusses concerns about Oxford/AstraZeneca vaccine data

23 Mar 2021, 12:16 PM, Good Morning America, ABC News


Update following statement by NIAID on AZD1222 US Phase III trial data

23 Mar 2021, 12:11 PM, Staff Writer, AstraZeneca


AstraZeneca may have included 'outdated information' in Covid vaccine trial, U.S. health agency says

23 Mar 2021, Sam Meredith, CNBC


INTERVIEW: BioNTech founders Özlem Türeci and Ugur Sahin on developing the BioNTech-Pfizer COVID-19 vaccine, the future of fighting cancer, and whether people can live to 200

23 Mar 2021, Mathias Döpfner, Business Insider


AstraZeneca says COVID-19 vaccine found 79 percent effective in US trial

22 Mar 2021, 10:40 AM, Staff Writer, The Hill


AstraZeneca’s Covid-19 Vaccine Is Found to Be 79% Effective in U.S. Study

22 Mar 2021, Rebecca Robbins, New York Times


USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective

22 Mar 2021, Staff Writer, ox


AstraZeneca’s Covid-19 vaccine shows better-than-expected efficacy

22 Mar 2021, Matthew Herper, STAT